lead

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

7 months ago

Vodafone Qatar selects Nokia in major network modernization deal to drive expanded 5G coverage, reliability, and services

Press ReleaseVodafone Qatar selects Nokia in major network modernization deal to drive expanded 5G coverage, reliability, and services The deal…

7 months ago